Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Novo Nordisk: CagriSema Could Be a Game-Changer

Planlagt Fastgjort Låst Flyttet Debatforum
5 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #1

    Novo Nordisk has been one of the biggest stories in global healthcare, but after a massive drop, is this the turning point investors have been waiting for? In today's video, I'll break down whether Novo Nordisk (NYSE: NVO) can stage a comeback after months of turbulence.

    ✅ The surprising reason behind Novo Nordisk's 54% drop this year
    ✅ What Wall Street's latest ratings reveal about NVO's real potential
    ✅ How CagriSema and other GLP-1 drugs could fuel the next rally
    ✅ Why the $5.2B Akero Therapeutics deal might be smarter than it looks
    ✅ The leadership shake-up that's shaking investor confidence and why it might not be all bad
    ✅ What to watch for next in the FDA approval pipeline

    I'll walk through the bullish case, the major risks, and the one catalyst that could send shares soaring again. By the end, you'll have a clear view of whether Novo Nordisk is a recovery play or a value trap.

    Skip ahead:
    0:00 - Intro
    2:22 - NOVO's overview
    4:46 - NVO's price
    6:06 - Growth catalysts
    8:35 - Risks and red flags
    10:49 - Analyst verdict

    1 Reply Last reply
    4
    • Ø Offline
      Ø Offline
      Øbo
      wrote on sidst redigeret af
      #2

      Ikke den mest informerede youtuber

      1 Reply Last reply
      0
      • B Offline
        B Offline
        B.Andersen
        wrote on sidst redigeret af
        #3

        Han har fokus på nogle interessante emner i casen som investorerne ikke har fokus på lige for tiden.

        1 Reply Last reply
        3
        • OccamO Offline
          OccamO Offline
          Occam
          wrote on sidst redigeret af
          #4

          Han kommer vidt omkring, startende med Adam og Eva; læs August og Marie.

          Han peger på ejerforholdene. Kun 11% er institutionelt ejet. Dvs. de fleste aktier ligger hos retail investors. Om disse siger han, at de læser ikke regnskaber, kun overskrifter.

          Det giver en god forklaring på Novos underlige kursudvikling. I den yderste konsekvens styres kursen af mediernes behov for at fortælle sensationer - uanset om de er rigtige eller forkerte, væsentlige eller uvæsentlige.

          Men hvorfor køber de institutionelle så ikke nu?

          1 Reply Last reply
          3
          • B Offline
            B Offline
            B.Andersen
            wrote on sidst redigeret af
            #5

            Should You Buy Novo Nordisk After the Huge Investor Update? ' NOVO Stock ' Top 10 Vote Winner!

            1 Reply Last reply
            2
            • P Offline
              P Offline
              pauly
              wrote on sidst redigeret af
              #6

              Synes han har nogle rimelige betragtninger

              1 Reply Last reply
              2

              Hello! It looks like you're interested in this conversation, but you don't have an account yet.

              Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

              With your input, this post could be even better 💗

              Tilmeld Log ind

              • Log ind

              • Har du ikke en konto? Tilmeld

              • Login or register to search.
              • First post
                Last post
              0
              • Debatforum
              • Seneste
              • Populære
              • Bruger